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Highlights 
 Cell cycle arrest in senescence is not a binary switch between cycling and non-cycling 
states 
 Cells approaching senescence show elongated cell cycle times prior to permanent 
arrest 
 Clonal heterogeneity among diploid fibroblasts is not restricted to cells undergoing 
senescence 
 Cells showing a telomere-related DNA-damage response can continue to cycle 
 Cells showing a doxorubicin-induced DNA-damage response can also continue 
cycling 
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 Abstract 
In replicative senescence, cells with critically-short telomeres activate a DNA-damage 
response leading to cell-cycle arrest, while those without telomere dysfunction would be 
expected to cycle normally.  However, population growth declines more gradually than such 
a simple binary switch between cycling and non-cycling states would predict.  We show here 
that late-passage cultures of human fibroblasts are not a simple mixture of cycling and non-
cycling cells.  Rather, although some cells had short cycle times comparable to those of 
younger cells, others continued to divide but with greatly extended cycle times, indicating a 
more-gradual approach to permanent arrest.  Remarkably, in late passage cells, the majority 
showed prominent DNA-damage foci positive for 53BP1, yet many continued to divide.  
Evidently, the DNA-damage-response elicited by critically-short telomeres is not initially 
strong enough for complete cell-cycle arrest.  A similar continuation of the cell cycle in the 
face of an active DNA-damage response was also seen in cells treated with a low dose of 
doxorubicin sufficient to produce multiple 53BP1 foci in all nuclei.  Cell cycle checkpoint 
engagement in response to DNA damage is thus weaker than generally supposed, explaining 
why an accumulation of dysfunctional telomeres is needed before marked cell cycle 
elongation or permanent arrest is achieved. 
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 1. Introduction 
Replicative senescence – a state of permanent cell cycle arrest following prolonged 
proliferation (Hayflick 1965) – is due primarily to the erosion of telomeres, the specialized 
nucleotide repeat structures that protect the ends of linear eukaryotic chromosomes 
(Harley 1991; Lundberg et al. 2000; Serrano and Blasco 2001; Wright and Shay 2001).  
Because DNA polymerases are unable to replicate fully the ends of linear DNA molecules, 
telomeric DNA shortens with each round of DNA replication (Harley 1991).  Germ cells (and 
some stem cells) express the enzyme telomerase which adds back multiple hexanucleotide 
repeats to compensate for this shortening (Hiyama and Hiyama 2007; Wright et al. 1996).  
However, most somatic cells lack telomerase and can therefore undergo only a finite 
number of divisions before telomeres erode to the point where they resemble double-
stranded DNA breaks, which evoke a DNA damage response leading to a loss of proliferative 
capacity and the cessation of culture growth (d'Adda di Fagagna et al. 2003; Rossiello et al. 
2014).  Telomere erosion can be prevented by ectopic expression of the telomerase reverse 
transcriptase catalytic subunit (TERT), which reconstitutes telomerase activity (Colgin and 
Reddel 1999).  For human fibroblasts this is generally sufficient to prevent replicative 
senescence and “immortalize” the cells (Bodnar et al. 1998).   
 
In its simplest form, the telomere-shortening hypothesis predicts a relatively abrupt loss of 
proliferative capacity towards the end of culture lifespan, as telomeres become critically 
short (Levy et al. 1992).  However, it is well known that proliferative capacity is highly 
heterogeneous, even between sister cells, with non-dividing cells appearing from the 
earliest passage (Absher and Absher 1976; Absher et al. 1974; Ponten et al. 1983; Smith and 
Whitney 1980).  To account for the heterogeneity, Blackburn suggested that stochastic 
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 telomere uncapping, rather than shortening per se, may be the critical event leading to the 
loss of proliferative capacity (Blackburn 2000).  It is also known that telomeric DNA is 
especially sensitive to oxidative damage which can thus accelerate the shortening (von 
Zglinicki et al. 1995; von Zglinicki et al. 2000).  Moreover, even without significant 
shortening, damaged telomeres are resistant to repair in the absence of adequate 
telomerase activity, and accumulate in aging tissues (Fumagalli et al. 2012; Hewitt et al. 
2012; Rossiello et al. 2014).  Thus, random damage to telomeres, through exposure to 
reactive oxygen species (Passos et al. 2007), or other stresses including stalled replication 
forks (Suram et al. 2012), could also contribute to the observed heterogeneity in 
proliferative capacity and the early appearance of senescent cells, even in the absence of 
detectable telomere shortening (Ferenac et al. 2005; Pitiyage et al. 2010; Victorelli and 
Passos 2017).   
 
The DNA-damage response elicited by critically short or damaged (“dysfunctional”) 
telomeres results in the upregulation of p53, which in turn causes cell cycle arrest through 
the expression of p21 (CDKN1A), an inhibitor of the cyclin-dependent kinases (CDKs) needed 
for cell cycle initiation and mitosis (Brown et al. 1997; Wynford-Thomas 2000).  
Nevertheless, although the link between dysfunctional telomeres and the DNA-damage 
response is well established, it remains unclear just how quickly permanent cell cycle arrest 
is achieved.  Given the suggestion that just a single DNA double-strand break is sufficient for 
proliferative arrest (Di Leonardo et al. 1994), the onset of arrest at the cellular level in 
response to dysfunctional telomeres is widely regarded as an abrupt, all-or-none 
consequence of activating the DNA-damage response.  In keeping with this, while the 
growth fraction drops progressively with passage, the cycle times of the few cells 
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 proliferating in late-passage cultures are reported to be identical to those of young cells 
(Bell et al. 1978; Karatza et al. 1984; Ponten et al. 1983), compatible with the idea that the 
onset of senescence is a binary switch between cycling and non-cycling states (Bell et al. 
1978; Shall and Stein 1979).  However, others have reported that cycle times are elongated 
in late passage cultures (Macieira-Coelho et al. 1966) suggesting a more-gradual approach 
to proliferative arrest.  Dysfunctional telomeres, positive for the DNA-damage marker γ-
H2AX, have also been observed in metaphase spreads, indicating that cells with an active 
telomeric DNA-damage response must nevertheless be able to progress into mitosis (Kaul et 
al. 2011).  On statistical grounds, it was estimated that the accumulation of 5 dysfunctional 
telomeres was necessary for irreversible cell cycle arrest (Kaul et al. 2011). 
 
Further evidence in favour of a gradual approach to cell senescence has come from studies 
by Kim et al. (2013) which showed progressive changes in gene expression and various 
markers of cell senescence (e.g. increased cell size, area, and β-galactosidase staining) over 
many weeks after cell doubling time first began to increase.  However, these studies were 
population-based so it was not possible to tell whether the increases in doubling times were 
due to decreases in growth fraction or a lengthening of the cell cycle, or both, while the 
changes in gene expression or cell senescence markers may have occurred in response to 
prolonged arrest, only in cells that had permanently left the cell cycle.  The details of how 
and when permanent cell cycle arrest is reached are therefore important but remain to be 
established. 
 
To clarify the kinetics of cell cycle arrest at the cellular level in response to telomere 
dysfunction, population-based methods of analysis such as BUdR labelling or flow cytometry 
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 are inadequate, as they give limited information about the variability and heterogeneity of 
cell cycle times within a population.  Instead, direct measurements of cell cycle duration by 
time-lapse microscopy of individual cells are needed.  Some such studies for human diploid 
fibroblasts have already been reported (Absher and Absher 1976; Absher et al. 1974; Absher 
et al. 1975).  However, the published data are for selected individual clones at different 
passage levels, and do not give the full measure of cell cycle variability and heterogeneity 
across a whole population.  Furthermore, the cultures were not in steady state, making the 
cell cycle time distributions difficult to interpret (Shields 1979; Smith 1977).  We have 
therefore undertaken further time-lapse studies of human diploid fibroblasts as they 
approach senescence and have compared the cycle time distributions to those of identical 
cells immortalized by telomerase.  We find that clonal heterogeneity is not restricted to cells 
undergoing senescence but is also seen with immortalized cells.  The variability of cell cycle 
times is substantial, even for immortalized cells, ranging from around 10 hours to more than 
90 hours – much greater than commonly realized.  In late-passage cultures of normal 
fibroblasts, some cells continue to divide with cycle times similar to those of earlier passage 
or immortalized cells.  However, others divide only after greatly extended cycle times 
suggesting that the onset of growth arrest in senescence is not a simple, irreversible binary 
switch between cycling and non-cycling states but involves a more gradual slow-down in 
proliferation.  Of particular note, we find that many late passage cells continue to cycle 
despite the presence of prominent telomere-related DNA-damage foci.  This suggests that 
the initial DNA-damage response evoked by dysfunctional telomeres is not sufficient for 
immediate, permanent arrest.  This is not because DNA-damage signalling from 
dysfunctional telomeres is ineffective in some way since we find that cells treated with a low 
dose of doxorubicin also continue to cycle while showing an active, DNA-damage response.  
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 Rather, cell cycle checkpoint engagement in response to DNA damage is weaker than 
generally supposed.  This explains why an accumulation of dysfunctional telomeres, through 
continued cycling, is needed before marked cell cycle elongation or permanent arrest is 
achieved. 
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 2. Materials and Methods 
2.1 Cell culture 
Hs68 neonatal foreskin fibroblasts (ATCC: CRL 1635) and dermal fibroblasts from a 24 year 
old male homozygous for a 19 bp deletion in exon 2 of the CDKN2A gene (Leiden cells), 
together with their TERT-immortalized counterparts (Brookes et al. 2002) were kindly 
provided by Gordon Peters (CRUK, London).  In Leiden cells, the CDKN2A deletion 
specifically eliminates p16Ink4a function while retaining a fully functional ARF (Brookes et al. 
2002).  The cells were grown routinely at 37°C and 8% CO2 in Dulbecco’s modified Eagle’s 
medium (DMEM) containing 25 mM glucose, 1 mM sodium pyruvate and 10% foetal calf 
serum (FCS), hereafter referred to as growth medium.  In most cases, the cells were cultured 
in 25 cm2 tissue culture flasks (Nunc) with 7 ml of growth medium and an initial seeding 
density of 0.5 x 105cells/flask.  However, for the Hs68 growth curves in Fig.1, the cells were 
grown in 80 cm2 tissue culture flasks (Nunc) with 14 ml of growth medium, and an initial 
seeding density of 2.5 x 105cells/flask.  The cells were subcultured at weekly intervals for the 
most part, with a medium-change on day 3 or 4.  For subculture, the cells were detached 
using 0.05% (w/v) trypsin (GIBCO) in Dulbecco’s phosphate buffered saline solution A (PBSA) 
containing 0.02% (w/v) EDTA, counted using a haemocytometer, and the number of 
population doublings achieved in that passage calculated.  As the normal fibroblast cultures 
neared the end of their life-span, the interval required to reach confluence (and subculture) 
increased.  They were considered to have reached their terminal passage when cell number 
failed to double over an interval of 4 weeks, with twice-weekly medium changes.  Because 
lifespan (maximum number of population doublings achieved) varied slightly with different 
batches of FCS, in order to compare experiments over time, cell growth was expressed as a 
fraction of the completed lifespan. 
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2.2 β-Galactosidase staining 
Cells were rinsed twice with PBSA, fixed with 2% formaldehyde/0.2% glutaraldehyde in PBSA 
and stained for senescence-associated (SA) β-galactosidase (at pH 6.0), as described (Dimri 
et al. 1995). 
 
2.3 Time-lapse films 
For time-lapse microscopy, 2 x 103 cells were seeded in a 0.1 ml drop of growth medium in 
the centre of a 25 cm2 flask.  After incubation at 37°C for at least 30 minutes to allow the 
cells to attach, the flasks were flooded with 7 ml of growth medium and returned to the 
incubator to equilibrate.  The local cell density achieved was comparable to the seeding 
density in routine subculture, but the total number of cells in the flask was far less (only 2%), 
in order to minimise medium depletion during the course of a film.  For filming, the flask 
was transferred to a Zeiss inverted microscope fitted with a heated stage set to achieve a 
temperature of 37°C within the flask.  The flask was covered with a clear Pyrex “hot plate”, 
which had a heating element painted on to it (Riddle 1983) and maintained at a 
temperature slightly above 37°C, to prevent the build-up of mist on the top surface of the 
flask. The flask was surrounded by an expanded polystyrene jacket cut to fit around it, and 
covered by a clear Perspex box placed over it on top of the stage as an insulator, to help 
keep the temperature of the flask constant.  Filming was started 1-3 days after plating, to 
ensure the cells had resumed exponential growth following subculture.  Images were 
captured using a monochrome video camera and Panasonic time-lapse video recorder at 
one frame per minute, or later with a Moticam digital camera, at 15 minute intervals. 
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 Using the films, individual cells were tracked until they divided, died or were lost from view.  
Dead cells or cells dividing abnormally were noted but discarded from the analysis of 
division times.  Cells lost to view were included in the analysis up to the point they were 
lost, as described (Smith 1977). 
 
2.4 Immunofluorescence staining for 53BP1 
Cells were seeded into 3 cm dishes (Nunc) at 2 x 104 per dish in 2 ml of medium (DMEM plus 
10% FCS), and used 4-5 days later.  After first rinsing with PBSA (DIFCO), the cells were fixed 
with methanol at -20°C for 5 minutes, and air-dried.  Using an inverted 0.5 ml microfuge 
tube as a template, a grease circle was painted around the cells in the centre of the dish 
using a cotton bud dipped in petroleum jelly.  Cells within the circle were then rehydrated 
with PBSA containing 1% bovine serum albumin (BSA) for 5 mins, and incubated overnight at 
4°C with 20 μl of rabbit anti-53BP1 (Cell Signalling Technology, Cat. 4937) diluted 1:100 in 
PBSA containing 1% BSA and 0.15% sodium azide.  After removing the primary antibody, the 
cells were rinsed x3 with PBSA before staining with 20 μl of AlexaFluor 488-conjugated goat 
anti-rabbit IgG (H+L) from Molecular Probes (Life Technologies, Cat. A-11008), diluted 1:100 
in PBSA containing 1% BSA and 0.15% sodium azide, for 60 minutes at 37°C.  Following 
removal of the secondary antibody, the cells were rinsed x3 with PBSA, then stained for DNA 
with 4’,6’-diamidino-2-phenylindone (DAPI) at 1 μg/ml in PBSA for 5 minutes, and finally 
covered with a 22 mm coverslip mounted using Fluorosave (Calbiochem).  The cells were 
then examined using an Olympus PROVIS AX70 microscope.  Fluorescence images were 
captured using a Zeiss Axiocam digital camera using the AxioVision software. 
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 3. Results 
3.1 Progressive decline in cell density at confluence prior to senescence 
The growth characteristics of the Hs68 fibroblasts used in this study are shown in Fig. 1.  
They typically reached 60-70 population doublings (Fig. 1A), before entering a state of stable 
growth arrest in which the cells were positive for “senescence-associated” β-galactosidase 
(Fig. 1B).   
For the growth curves in Fig. 1A, the cells were subcultured shortly after the attainment of 
confluence, in late-logarithmic growth.  The cell density attained is therefore close to 
saturation and delaying subculture would make little difference to the number of cells 
harvested.  It is noteworthy that the cell density at confluence dropped progressively with 
passage, long before the slow-down in population growth associated with senescence 
became apparent.  This decline in cell density was invariable over many similar experiments, 
and indicates an early increase in average cell area during progression to senescence, as 
reported by Kim et al. (2013).  It was also seen with fibroblasts (“Leiden cells”) derived from 
an individual bearing inactivating mutations in both alleles of the p16Ink4A (CDKN2A) gene 
(Supplementary Fig. S1) and is not therefore dependent on the expression of p16, the 
Cdk4/6 inhibitor implicated in telomere-independent senescence in some cell types 
(Serrano and Blasco 2001).  Rather, the decline is an early manifestation of telomere 
dysfunction since it is not seen when the cells are immortalized with TERT (Fig. 1A and Fig. 
S1).  If the transition between cycling and non-cycling states in senescence were abrupt, a 
decline in cell density at confluence would not be expected until near the end of culture 
lifespan, since the small, not-yet-senescent cycling cells should continue to proliferate 
unhindered, filling up the culture surface.  However, we do not see nests of small, cycling 
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 cells interspersed amongst large, non-cycling (senescent) cells (Fig. 1B).  Rather, the steady 
decline in saturation density with passage suggests a more-gradual transition to cell-cycle 
arrest than a simple switch might predict. 
3.2 Late passage cells continue cycling with extended cycle times 
3.2.1 Time-lapse analysis 
In its simplest form, the telomere dysfunction hypothesis of replicative senescence predicts 
a binary switch from a proliferative to a non-proliferative state such that cells with critically 
short or damaged telomeres undergo arrest while the rest continue to cycle normally 
(Blackburn 2000).  To determine if this was the case, given the rather gradual decline in 
saturation density over time in Fig. 1, late passage Hs68 cells were followed by time-lapse 
microscopy and their cell-cycle behaviour compared with that of mid-passage cells, or cells 
immortalized with TERT.  Typical cell pedigrees for one such representative experiment are 
shown in Fig. 2A-C.  The full set of pedigrees is given in supplementary Fig. S2A-C, and the 
complete listing of cell division times in Tables S1A-C.  Details of how the cell division times 
are codified are indicated in Fig. S3.   
 
Many TERT-immortalized cells could be followed through three consecutive divisions (two 
complete cell cycles) or more (Fig. 2A; Supplementary Fig. 2A).  In contrast, the late-passage 
cells (85% of completed lifespan, corresponding to 58 population doublings in Fig. 1A) 
underwent far fewer consecutive cell cycles in a similar interval (Fig. 2C; Supplementary Fig. 
2C), some cells failing to divide at all and others only after extended cell cycle times (e.g. 
cells 21 and 22).  The late-passage cells (being flatter) were also much harder to follow, 
identity often becoming ambiguous after collisions with adjacent cells.  As a result, many 
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 more cells were marked as “lost”.  The mid-passage Hs68 cells (64% of completed lifespan, 
corresponding to 44 population doublings in Fig. 1A) showed intermediate behaviour 
compared to the late-passage cells and TERT-immortalized cells (Fig. 2B; Supplementary Fig. 
2B).   
Clonal heterogeneity has long been recognized as a feature of normal diploid cells (Absher 
and Absher 1976; Absher et al. 1974; Ponten et al. 1983; Smith and Whitney 1980) and is 
clearly evident here.  For example, cell 32 (mid-passage cells, Fig 2B) does not divide until 
90.5 hour after the start of the film.  This is more than 9 times the minimum cycle time for 
these cells (9.75 hours) and a point when other cells have undergone up to four consecutive 
divisions (e.g. cell 31, Fig 2B).  However, such heterogeneity is also seen with TERT-
immortalized cells.  For example, cell 46 (Fig 2A) divides at the very start of the film.  One of 
its daughters is subsequently lost but the other does not divide again until after 61.5 hours, 
a point when adjacent cells have completed up to three consecutive cycles (e.g. cells 45 and 
47, Fig 2A).  Heterogeneity in TERT-immortalized cells is also observed within clones.  For 
example, cell 13 (Supplementary Fig. S2A) divides 4.5 hours after the start of the film.  One 
of its daughters does not divide again until after a further 95 hours, while its sibling 
completes two further cell cycles in the same interval.  Heterogeneity in proliferative 
capacity is clearly not restricted to cells undergoing replicative senescence. 
 
3.2.2 Distribution of times to first mitosis after the start of filming 
The kinetics of entry into mitosis are shown in Fig. 3A.  For the TERT-immortalized cells, 
roughly 96% of the 60 cells followed reached mitosis during the 114.5 hours of the film (Fig. 
3A), the longest recorded time to first mitosis being 59.75 hours (cell 11, Fig. S2A).  Two cells 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 were followed for longer than this without dividing, but were lost before the end of the film 
(cells 20 and 21, Fig. S2A).  Considering that the cells are growing at their maximal rate, 
under optimal conditions, the range of times to first division (0 to >59.75 h) is very large, 
indicating a degree of cell cycle variability that is rarely appreciated. 
 
For the mid-passage cells (64% completed lifespan) and late-passage cells (85% completed 
lifespan), the initial rate of entry into mitosis appears lower than for the TERT-immortalized 
cells (Fig. 3A).  This is most likely due to differences in the degree of synchrony following 
replating of the cells which affects the proportion already in S or G2 at the start of the film.  
The rate of entry into the cell cycle is better assessed by considering the cohort of cells 
dividing after the minimum cycle time for these cells (9.75 hours, in this case).  This cohort 
corresponds roughly to the cells in G1 not yet committed to the next cycle at the start of the 
film.  (Cells dividing in the initial segment of the film up to the minimum cycle time would be 
mainly those already in S or G2 at the start of the film.)  As seen in Fig. 3B, the initial rate of 
entry into mitosis for this “G1 cohort” is essentially identical for all three cultures.  For the 
mid-passage and TERT immortalized cells, the rates are similar over the entire film, though 
with a possible slight excess of very long cycle times in the mid-passage cells.  However, for 
the late-passage cells, there is a marked slow-down in entry into mitosis after the first 30% 
of the cohort divides, indicating a reduced probability of cell cycle initiation.  The longest 
recorded division time was 116.75 hours (cell 35 in Supplementary Fig. S2C), roughly 12 
times greater than the minimum cycle time for these cells (9.75 hours); 9 other cells were 
followed to the end of the film (145 hours) without dividing. 
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 Apart from the cell cycle slow-down seen with the late-passage cells, it is also noteworthy 
that 5 of the 55 cells tracked died without dividing, during the course of the film 
(Supplementary Fig. S2C).  In contrast, no cell death was observed prior to first mitosis in the 
films of mid-passage or immortalized cells (Supplementary Fig. S2A, B).   
 
The data in Fig. 3A might suggest a decrease in growth fraction with passage, as reported by 
others (Cristofalo and Sharf 1973; Karatza et al. 1984; Ponten et al. 1983).  Thus, only 69% of 
the late passage cells divided at least once during the 6 days (145 hours) of the film, 
compared to 96% with the immortalized TERT cells.  Nevertheless, it cannot be concluded 
that all of the cells remaining undivided at the end of the film were permanently incapable 
of further division since many of them may have reached mitosis had the period of 
observation been even longer.  Indeed, this seems likely, since the plot of undivided cells 
against time does not plateau in the late passage culture but continues to fall throughout 
the period of observation, albeit at a very low rate.  What is certain is that the late passage 
culture shows an increase in the proportion of cells dividing with extremely long cycle times, 
compared to the mid-passage culture. 
 
3.2.3 Cycle times 
The progeny of the cells dividing were followed until they in turn divided or were lost to 
view, in order to determine complete cell cycle duration.  The resulting first generation cycle 
times are shown as “alpha curves” (Kaplan–Meier plots) (Brooks et al. 1980; Smith and 
Martin 1973) in Fig. 3C or as frequency histograms (complete cycle times only) in Fig. 4.  The 
distributions of cycle times for the mid-passage cells (64% completed lifespan) and the 
TERT-immortalized cells were virtually identical (Fig. 3C; Fig 4A,B) with a growth fraction of 
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 essentially 100%, indicating that the mid-passage cells which divide generate progeny that 
remain highly proliferative.  In contrast, for the late passage cells (85% completed lifespan), 
only 54% of the cells divided for a second time (i.e. one complete cell cycle) during the 
period of observation (Fig. 3C).  The first of those to reach the second mitosis (around 15% 
of the cohort) had cycle times comparable to the shortest in the mid-passage and TERT cells 
(note the initial overlap in the alpha plots in Fig. 3C), but thereafter there was a shift 
towards longer cycle times (Fig. 3C; Fig. 4C).  Thus, in the late passage culture, although 
some cells still cycled as rapidly as TERT-immortalized cells, others did so with extended 
cycle times, as found for times to first mitosis (Fig 3A).  What is not found is a simple 
bifurcation between rapidly-dividing and non-dividing (growth-arrested) states. 
 
3.3 Late passage cells show DNA damage foci yet continue to divide. 
To determine the association between full growth arrest, cell cycle elongation and the 
telomere-dysfunction-induced DNA-damage response, cells were stained with an antibody 
to 53BP1, a well-established marker of DNA-damage (d'Adda di Fagagna et al. 2003).  
Examples of nuclei with one, two and three prominent 53BP1-positive foci are shown in Fig. 
5.  For late-passage cells (84% completed lifespan), the fraction of positive cells was high, 
with 80% of the cells having at least one 53BP1-focus, and 20% having 3 or more (Fig. 6A).  
In contrast, only 15% of TERT-immortalized cells were positive (Fig. 6A), the majority of 
these having a single focus that was generally smaller than those seen in the non-
immortalized cells (bottom row, Fig.5).  The few, small foci seen in the TERT-cells are most 
likely a measure of “spontaneous” (random) DNA damage due (for example) to oxidative 
stress or incomplete replication (Arora et al. 2017; Barr et al. 2017).  However, it has also 
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 been shown (Lee et al. 2015) that telomere extension in telomerase-expressing cells 
requires ATM-kinase function (usually co-localized with 53BP1 – d'Adda di Fagagna et al. 
2003), raising the possibility that a transient DNA-damage response is a normal part of 
telomerase-dependent telomere maintenance.  But regardless of the origin of the few small 
foci in TERT-immortalized cells, it seems clear that the majority of the (much larger) foci 
found in the non-immortalized cells are a consequence of telomere dysfunction since they 
are not seen in cells expressing telomerase. 
 
In a parallel culture followed by time-lapse microscopy, 58% of the cells present in the field 
of view divided at least once over a 200 hour period (Fig. 6B), comparable to the late-
passage cells in Fig. 3.  However, only 20% of the cells had no 53BP1-foci (Fig. 6A).  
Assuming, conservatively, that all these 53BP1-negative cells were among those that 
divided, it follows that the remaining 38% of cells (i.e. 58% minus 20%) that divided must 
have done so despite the presence of one or more prominent DNA-damage foci.  Clearly, 
the presence of telomere-related DNA-damage foci does not identify the subpopulation of 
arrested, non-cycling cells.  The DNA-damage response evoked by dysfunctional telomeres is 
evidently not always strong enough to bring about immediate, permanent cell cycle arrest.   
 
Similar results were obtained with p16-null Leiden fibroblasts.  The fraction of 53BP1-
positive cells increased steadily with subculture, reaching 93% in late passage cells (87% 
completed lifespan, Fig 6C).  As with Hs68 cells, the majority of these 53BP1 foci must have 
been associated with telomere dysfunction since only around 9% of immortalized Leiden-
TERT cells had any such foci in this experiment (Fig 6C).  In a comparable late-passage 
culture followed by time-lapse microscopy, 46% of the cells entered mitosis and divided 
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 over the 200 hour period of observation (Fig 6.D).  Since 93% of the population was positive 
for 53BP1 foci, the majority of these dividing cells must have done so in spite of an active 
DNA-damage response.   
 
Assuming that the 54% of cells remaining undivided at the end of the film were permanently 
arrested, this fraction was subtracted to give the times to mitosis of the dividing fraction (Fig 
6D).  As with late passage Hs68 cells (Figs 3 and 4), the dividing cells had extended cycle 
times compared to their TERT-immortalized counterparts (Fig 6D).  In this case, since these 
cells lack p16, it can be concluded that this cell cycle elongation does not depend on p16 
expression. 
 
The continued entry into mitosis of late-passage cells in spite of a telomere-related DNA-
damage response raised the possibility that progress through mitosis might nevertheless be 
perturbed, due for example to centrosome amplification or end-to-end chromosome fusions 
(Smogorzewska and de Lange 2002).  To examine this, the duration of mitosis (from 
rounding up to the onset of cytokinesis) was compared for late-passage cells (both Hs68 and 
Leiden cells) and their TERT-immortalized counterparts (Fig 7A, B).  For most cells, the 
duration of mitosis was between 45-60 minutes.  However, for the late-passage cultures 
(both Hs68 and Leiden fibroblasts) there was a significant increase in the number of cells 
undergoing a prolonged mitosis (>75 min).  Some of these appeared to be multipolar 
mitoses, though in all cases here these resolved (after a delay) to give two viable daughters, 
sometimes of unequal size.  In a few cases, daughter cells remained connected by a thin 
cytoplasmic process for an extended interval, suggestive of possible anaphase bridges.  It 
thus seems likely that entry into mitosis by cells with telomere dysfunction is not without 
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 consequence, consistent with the high frequency of abnormal nuclei (morphology, size, 
ploidy) commonly seen in senescent cultures, e.g. Sherwood et al. (1988); Smogorzewska 
and de Lange (2002). 
 
3.4 Cells with DNA-damage induced by doxorubicin also continue to enter mitosis 
The continued division of cells with telomere-related DNA-damage foci (Fig 6B, D) was 
surprising and raised the possibility that the DNA-damage response evoked by dysfunctional 
telomeres might be incomplete in some way and activate cell cycle arrest more weakly than 
DNA breaks elsewhere in the genome.  To examine this, TERT-immortalized Hs68 cells were 
treated with 0.2 M doxorubicin for 1 hour.  This induces a strong DNA-damage response 
(multiple 53BP1 foci) in 100% of the cells (Fig 8A), which persists for many hours.  Indeed, 
even after 24 hours, more than 80% of the cells continue to show one or more 53BP1 foci 
(not shown).  Two hours after doxorubicin removal, to allow time for induction of 
downstream DNA-damage signalling, filming of the cells was commenced.  Remarkably, 
from the start of filming, the cells continued to divide at much the same rate as untreated 
cells (Fig 8B).  Although some attempts at division were abnormal (prolonged rounding up, 
multipolar mitosis, failure of cytokinesis), as marked by the closed diamonds () in Fig 8B, it 
is clear that there was no early block to entry into mitosis.  Of the cells followed, only 
around 20% underwent a prolonged cell cycle arrest (no division for up to 100 hours).  
When this non-dividing cohort is subtracted, the times to mitosis for the dividing fraction 
were superimposable on the control over the entire range (not shown).  Thus, despite 
substantial DNA damage in all cells (Fig 8A), 80% of the cells continued through the cell cycle 
with little if any delay.  
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 To determine the subsequent fate of the doxorubicin-treated cells that divided, their 
daughters were followed through the next cell cycle.  Almost 60% of these were observed to 
divide again during the course of the film, though with somewhat elongated cycle times 
compared to the control cells (Fig 8B, inset).  Thus, although the doxorubicin-treated cells 
showed little perturbation in the first cell cycle, there was some delay in the subsequent 
cycle, comparable to the extended cycle times seen in late passage cells (Figs 3, 4, 6D).  
There is therefore little reason to suppose that DNA damage induced by doxorubicin 
produces a stronger activation of cell cycle checkpoints than does telomere dysfunction.  
Note however that when growing cells were re-plated and then exposed continuously to 
doxorubicin (after re-attachment), in contrast to the 1-hour treatment above, there was 
virtually complete suppression of cell division (not shown), confirming that Hs68 cells are 
fully capable of growth arrest in response to sufficient DNA damage. 
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 4. Discussion 
The telomere-dysfunction hypothesis of replicative senescence leads to an expectation that 
late-passage cultures should consist of a mixture of arrested cells (displaying an active, 
telomere-related DNA damage response) and cells cycling normally that have not yet 
acquired dysfunctional telomeres – given that telomere length is known to be 
heterogeneous both within and between cells of the same population (Allsopp and Harley 
1995; Levy et al. 1992).  This, in turn, is supported by reports that the few dividing cells 
present in high-passage cultures have cycle times identical to those of “young” cells (Bell et 
al. 1978; Karatza et al. 1984; Ponten et al. 1983).  However, such a binary switch between 
cycling and non-cycling states predicts a relatively abrupt approach to culture senescence as 
telomeres shorten (Levy et al. 1992), which we do not see.  Rather, with Hs68 fibroblasts 
(Fig.1), and p16-null Leiden fibroblasts (Fig S1), cell density at confluence drops 
progressively long before the terminal passage, suggesting a more-gradual approach to cell 
senescence.  This is consistent with the early increase in cell area at confluence reported by 
Kim et al. (2013). 
 
In order to explore the onset of cell cycle arrest and senescence at the cellular level, we 
have undertaken time-lapse studies of cells approaching senescence.  We find that while 
some late-passage cells do indeed continue cycling with cycle times comparable to young 
cells, others divide only after greatly extended cycle times.  This indicates a slowing of the 
cell cycle rather than complete arrest, confirming that the loss of proliferative capacity is 
acquired gradually and is not an abrupt, all-or-none transition.  Moreover, since similar 
results were seen with both Hs68 neonatal foreskin fibroblasts (Figs 3 and 4) and Leiden 
cells (p16-null adult skin fibroblasts) (Fig 6D), this slowing of the cell cycle is likely to be a 
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 general feature of cells approaching replicative senescence and one that does not require 
the induction of p16.   
 
To determine the relationship between cell cycle elongation/arrest and telomere 
dysfunction, cells were stained for the DNA-damage marker, 53BP1.  As expected, the 
proportion of cells positive for 53BP1 foci rose steadily with passage (Fig 6C), though not in 
cells expressing TERT, confirming that most, if not all, of the prominent foci are associated 
with telomere dysfunction.  However, surprisingly, at a point where 80% of Hs68 cells had at 
least one, prominent 53BP1 focus per nucleus (Fig 6A), 58% of the cells were seen to divide, 
by time-lapse microscopy, over a 200 hour period of observation (Fig 6B).  Assuming that 
the 20% of cells without foci were among the dividers, it follows that 38% of the cells must 
have continued to enter and complete mitosis despite the presence of an active DNA-
damage response.  Similarly, 46% of late-passage Leiden fibroblasts divided successfully (Fig 
6D) even though 93% of the cells were positive for 53BP1 foci (Fig 6C).  Clearly, the presence 
of 53BP1 foci does not identify a sub-population of non-cycling cells, though it most likely 
accounts for the elongated cycle times shown by many of the late passage cells that 
continue to divide.  Presumably, those with the longest cycle times and those that failed to 
divide at all during the 200 hours of observation, are the cells with the greatest number of 
DNA damage foci.  However, further work will be required to confirm this.   
 
The continued division of cells with telomere-related DNA-damage foci raises the question 
as to whether the damage is repairable or irreparable.  Given their much lower frequency in 
TERT-immortalized cells, most of the large 53BP1 foci seen here in normal late passage Hs68 
and Leiden fibroblasts (Fig. 5) are likely to be associated with telomere “uncapping” 
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 (unravelling of the T-loop and exposure of a DNA end) caused by replication-driven 
telomere shortening (Price, 2012), though co-staining for telomeres by fluorescence in situ 
hybridization (FISH) is formally required to confirm this.  With sufficient shortening, the 
uncapping is thought to become irreversible, leading to a persistent DNA-damage response 
to the chromosome end as a “break”.  However, in the early stages, there may be some 
degree of recapping (telomere “flip-flop” - Price, 2012; Blackburn, 2000) which could 
temporarily interrupt the DNA-damage response, allowing the cell cycle to resume.  It is also 
possible that some large 53BP1 foci are associated with double-strand breaks within the 
telomere, rather than an exposed end (Victorelli and Passos, 2017).  In rapidly proliferating 
cells, such telomere damage can be repaired by homologous recombination (Doksani and de 
Lange, 2016; Mao et al., 2016), though not in senescent cells (Mao et al, 2016).  Any such 
repair prior to full senescence could again interrupt the DNA-damage response allowing the 
cell cycle to resume.  Lastly, in senescent cells, some 53BP1 foci are not associated with 
telomeres but with DNA breaks elsewhere in the genome caused by increased levels of 
reactive oxygen species (ROS) (Passos et al, 2010).  Such foci are transient as a result of DNA 
repair.  Thus, it cannot be assumed that all of the 53BP1 foci seen here in late passage cells 
are permanent.  Is it possible therefore that the cells that divide are ones that temporarily 
lose all their foci?  We think not.  The very high frequency of positive cells (>90%, in Fig. 6C), 
maintained over time (and indeed rising with passage), means that any foci that disappear 
must be rapidly replaced by new foci, and it is difficult to see how any cells could be without 
all foci for the length of time needed to complete a cell cycle.  It therefore seems 
inescapable that some late passage cells are continuing to cycle in the presence of an active 
DNA-damage response.  Nevertheless, live-cell imaging of cells expressing a GFP-tagged 
53BP1 (Passos et al, 2010) is needed to confirm this.   
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Another explanation for how cells with telomere-related DNA-damage foci can continue to 
divide is that downstream signalling from dysfunctional telomeres is impaired compared to 
DNA breaks elsewhere in the genome, perhaps due to the suppression of DNA repair by 
telomere-associated proteins (Fumagalli et al. 2012; Hewitt et al. 2012; Rossiello et al. 
2014).  However, cells treated for a short time with a low dose of doxorubicin (sufficient to 
induce multiple DNA-damage foci in 100% of the cells) also continued to reach mitosis with 
comparatively little perturbation, though with some delay in the next cell cycle compared to 
control cells not treated with doxorubicin (Fig. 8).  Although surprising, this is in accord with 
other recent reports that cells with endogenous DNA damage are able to pass through 
mitosis, but with delay in the subsequent cell cycle (Arora et al. 2017; Barr et al. 2017; 
Harrigan et al. 2011; Koundrioukoff et al. 2013; Lukas et al. 2011; Moreno et al. 2016).  In 
particular, cells with 53BP1 foci were able to continue through G1 for resolution in S phase.  
From all this, there is no reason to think that non-telomeric DNA damage evokes a stronger 
block to the cell cycle than does telomere dysfunction.  Rather, cell cycle checkpoint 
engagement following DNA damage is evidently weaker than generally supposed, and only 
when the damage is substantial is prolonged arrest in G1 likely.  Nevertheless, many of the 
studies quoted above (including those in Fig. 8) employed immortalized cells, so some 
caution may be called for in extrapolation to fully normal, non-immortalized cells in general. 
 
Our results help to explain reports that an average of 5 dysfunctional telomeres is needed 
for permanent cell cycle arrest (Kaul et al. 2011).  Thus, it seems likely that the first critically 
short or damaged telomere is not enough to arrest the cell cycle, enabling the cell to go 
through further rounds of replication, permitting further telomere erosion or damage.  
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 Presumably, only after the accumulation of at least 5 dysfunctional telomeres is the level of 
p53 and p21 induction sufficient for complete cell cycle arrest.  Nevertheless, the late 
passage cells still contained some cells in S phase (Kaul et al. 2011).  Rather than total arrest, 
a continued low rate of entry into S phase leading to further telomere shortening and 
eventual chromosome fusion could explain both the increased cell death rate and the 
increased duration of mitosis in some cells observed here in late passage cultures, as well as 
the increase in polyploidy and chromosome aberrations noted by others in senescence 
(Sherwood et al. 1988; Smogorzewska and de Lange 2002).  The presence of unrepaired 
DNA-damage in late-passage cells could also sensitize them to apoptosis during subculture, 
accounting for the reduced plating efficiency of cells approaching senescence shown by 
many strains of human fibroblasts, including those used here (unpublished).  In addition, 
continued attempts to cycle in the face of unrepaired DNA-damage could account for the 
reduced viability seen in some fibroblast strains (e.g. WI-38 and IMR90) at very late passage, 
leading to the selective loss of cells with the highest extent of DNA-damage over time 
(Fumagalli et al. 2014). 
 
The cell pedigrees shown in Figs. 2 and S2 illustrate the extent of cell cycle variability in 
populations of human fibroblasts growing rapidly and as they approach senescence.  Even 
for TERT-immortalised cells under optimal conditions, the cell cycle times range from a 
minimum of around 10 hours to more than 90 hours (Fig. 3C), and there are many examples 
of proliferative heterogeneity both between and within clones (Fig. S2A), as previously 
reported for immortal mouse 3T3 cells (Brooks and Riddle 1988a).  Such heterogeneity is 
clearly not a distinguishing characteristic of cells undergoing senescence.  One important 
consequence of this is that attempts to assess growth arrest in senescence by labelling with 
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 BUdR or [3H]-thymidine for intervals of 24 hours (e.g. Fumagalli et al. 2014) or even 72 hours 
(e.g. Dimri et al, 1995), are wholly inadequate to establish permanent cell cycle exit, given 
that some immortalized cells have cycle times that are longer than this, in cultures growing 
optimally.  
 
The causes of cell cycle variability have been the subject of extensive debate over the years.  
According to one view, the variability is an intrinsic feature of the cell cycle resulting from 
the probabilistic, switch-like activation of one or two rate-limiting transitions (Smith and 
Martin 1973; Brooks et al. 1980).  Although the identity of the hypothetical transitions has 
never been established, recent plausible candidates include an RB-E2F bistable switch (Lee 
et al. 2010), abrupt degradation of the CDK2 inhibitor p27kip1 (CDKN1B) (Barr et al. 2016), or 
switch-like irreversible inactivation of APCCDH1, the ubiquitin ligase whose targets include 
SKP2 needed for degradation of p21 and p27kip1 (Cappell et al. 2016).  However, transition 
probability models do not readily account for the inter- and intra-clonal proliferative 
heterogeneity that becomes more extreme under limiting growth factor stimulation (Brooks 
and Riddle 1988b).  More recently, live-cell imaging of cells with fluorescent markers of cell 
cycle position has suggested that the transition between cycling and quiescent (G0-like) 
states can be governed by the level of p21 in the mother cell at the time of mitosis and 
inherited by the daughter cells, and that this in turn is determined by endogenous DNA 
damage (or incomplete replication) in the mother cell (Arora et al. 2017; Barr et al. 2017; 
Overton et al. 2014; Spencer et al. 2013; Yang et al. 2017).  Such endogenous DNA damage 
inherited from the previous cycle could well account for the limited clonal heterogeneity 
seen here in TERT-immortalized fibroblasts while the added response to dysfunctional 
telomeres could explain the increased heterogeneity and extended cycle times seen in late 
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 passage normal fibroblasts lacking telomerase.  Nevertheless, the fraction of TERT cells with 
DNA damage foci is generally less than 20%.  If this fraction is assumed to correspond to the 
cells with the longest cycle times, the remaining 80% of the cells still have cycle times 
ranging from roughly 10-45 hours (Fig. 3C).  Thus, a substantial fraction of the total cell cycle 
variability must be caused by something other than the response to DNA damage, such as 
the stochastic transitions postulated by transition probability models (Smith and Martin 
1973: Brooks et al. 1980). 
 
Lastly, it is worth noting that the increasing frequency of dysfunctional telomeres with 
passage would lead to increasing basal levels of p21 in the population which would 
negatively compete with mitogen signalling in regulating entry into S phase though 
inhibition of CDK4/cyclin D (Yang et al. 2017).  Thus, as levels of p21 rise, the cells would 
increasingly resemble cells starved of growth factors.  Given the relationship between 
saturation density and serum growth factor concentration (Holley and Kiernan 1968), this 
could provide an explanation for the progressive fall in saturation density with passage, as 
seen here (Fig. 1). 
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 Figure legends 
Figure 1 
Growth characteristics of Hs68 and Hs68-TERT cells.   
(A)  Population growth curves and cell density at subculture (confluence) for normal Hs68 
cells and their TERT-immortalized counterparts (CPD, cumulative population doublings). 
(B)  Hs68 cells stained for senescence-associated (SA) beta galactosidase at mid-passage 
(corresponding to 34 population doublings in A) or late passage (corresponding to 62 
population doublings in A).  Right-hand panels, bright field, showing SA beta-galactosidase; 
left-hand panels, corresponding phase contrast images.  Scale bar = 20 µm. 
 
Figure 2 
Sample cell pedigrees (numbered arbitrarily) from analysis of time-lapse films.   
(A) Hs68 cells immortalized with TERT; (B) mid-passage Hs68 cells (64% completed lifespan); 
and (C) late-passage Hs68 cells (85% completed lifespan).  For each panel, the tick marks on 
the abscissa are at 20 hour intervals.  Lines that do not end in a division indicate the point at 
which the cell was lost from view. 
 
Figure 3 
Cell division times for late- and mid-passage Hs68 fibroblasts and their TERT-immortalised 
counterparts. 
The data are derived from the full set of cell pedigrees in Supplementary Fig. S2, for 
immortalized Hs68-TERT fibroblasts, and normal Hs68 cells at mid passage (64% completed 
lifespan) or late passage (85% completed lifespan.  Lost cells were included in the analysis 
up to the point they were lost, as described (Smith 1977). 
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 (A)  Times to first mitosis after the start of filming.  For the late passage cells, the number of 
cells followed was 55, of which 6 died during the period of observation (145 hours).  For the 
mid-passage cells and TERT cells, the initial sample sizes were 76 and 60 respectively, with 
no cell death observed.  After ranking, the times to division were plotted as the fraction of 
cells not yet divided against time.   
(B)  Times to first mitosis for cells dividing 9.75 h (the minimum cycle time in this 
experiment) after the start of filming, roughly corresponding to the cohort of cells in G1 at 
the beginning of the film.  The initial sample sizes were 29 (TERT cells), 55 (mid-passage) and 
37 (late-passage).  Data plotted as in (A). 
(C)  First generation cycle times.  The daughters of cells dividing in panel A were followed 
until they in turn divided, died or were lost from view.  After ranking, the interdivision times 
were plotted as the fraction of cells not yet divided against cell age (hours).  For the late 
passage cells, the number of cells that could be followed was 51, of which 3 died without 
dividing before the end of the film.  For the mid-passage cells and TERT cells, the numbers of 
cells that could be followed were 89 and 92 respectively, with no cell death noted. 
 
Figure 4 
First generation cycle time distributions (complete interdivision times only). 
(A) immortalized Hs68-TERT fibroblasts;  (B) normal Hs68 cells at mid passage (64% 
completed lifespan);  (C) normal Hs68 cells at late passage (85% completed lifespan).  The 
sample sizes were 71, 62 and 17 respectively.  The data are from the full set of cell pedigrees 
in Supplementary Fig. S2. 
 
Figure 5 
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 Examples of DNA-damage foci (53BP1-positive) in moderately late passage normal Hs68cells 
or immortalized Hs68-TERT cells.   
Rows 1-4 show examples of nuclei with 0, 1, 2 and 3 prominent 53BP1-positive foci (Hs 68 
cells), disregarding minor speckles.  With immortalized Hs68-TERT cells, only small 53BP1-
positive foci were observed.  Row 5 shows an example of one such focus. 
 
Figure 6 
Continued entry into mitosis in late passage Hs68 and Leiden cells showing telomere-related 
DNA-damage foci. 
(A) Frequency of DNA-damage foci (53BP1-positive) per nucleus in late passage normal Hs68 
cells (84% completed lifespan; shaded bars), and immortalized Hs68-TERT cells (open bars), 
with the 95% confidence intervals as indicated.  (B) Times to first mitosis for late passage 
Hs68 cells (comparable to those in panel A).  Filming commenced 3 days after plating the 
cells.  (C) The frequency of 53BP1-positive Leiden cells increases with passage (% completed 
lifespan; shaded bars).  Also shown is the frequency of 53BP1-positive Leiden-TERT cells 
(open bar).  The error bars indicate the 95% confidence intervals.  (D) Times to first mitosis 
for late passage Leiden cells (comparable to the highest passage in panel C).  Filming was 
started 24 hours after plating and in this experiment there was a further lag of around 20 
hours before cell division resumed.  Also shown are the times to mitosis for the dividing 
fraction after subtraction of the non-dividing subpopulation (those still undivided at the end 
of the film), together with the distribution of intermitotic times for the immortalized Leiden-
TERT cells under the same conditions. 
 
Figure 7 
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 Duration of mitosis in late-passage Hs68 and Leiden cells in comparison to their TERT-
immortalized counterparts. 
Duration of mitosis for (A) the dividing late-passage Hs68 cells in Fig 6B, and (B) the dividing 
late-passage Leiden cells in Fig 6D, together with that for their TERT-immortalised 
counterparts under the same conditions.  For both (A) and (B), the difference between the 
two distributions (wild type vs. TERT-immortalised) is significant (Chi square, p <0.05).  In 
the time-lapse films used, images were captured at 15 minute intervals.  The duration of 
mitosis was taken from rounding up to the onset of cytokinesis. 
 
Figure 8 
Continued entry into mitosis in Hs68-TERT cells showing doxorubicin-induced DNA-damage 
foci. 
(A)  TERT-immortalised Hs68 cells were treated with 0.2 M doxorubicin (Dox) for one hour, 
rinsed twice with serum-free medium, returned to growth conditions and stained for DNA-
damage foci (53BP1) 1 hour later (right panels: Green, 53BP1; Blue, DAPI; scale bar = 20 
m).  Control cells (left panels) were treated similarly but without exposure to doxorubicin. 
(B)  Cells treated with 0.2 M doxorubicin (Dox), as in A, were filmed for 100 hours, starting 
2 hours after treatment, and the times to mitosis determined.  Control cells were filmed for 
40 hours.  Dashed line, Dox-treated; continuous line, control (no Dox).  Cells that attempted 
mitosis but which underwent an abnormal division are indicated with closed diamonds ().  
Inset:  The daughters of dividing cells were followed until they in turn divided and the (first 
generation) cycle times determined.  These are plotted as the fraction of undivided cells 
against cell age.  Dashed line, Dox-treated; continuous line, control (no Dox).  Axis labels as 
for the main figure.  
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